Closed consultation

Change in classification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets (ARM 87)

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

MHRA is seeking views on the reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets from pharmacy to general sale list.

This consultation ran from
to

Consultation description

This consultation seeks your views on the reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets from pharmacy (P) to general sale list (GSL).

Please comment on the proposal in the document above using the reply form that is included.

Comments should be sent to MHRA by 17 March 2014. Comments received after that date will not be considered.

Documents

Reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 17 February 2014